Immunization, Hib3 in Andorra
Andorra: Immunization, Hib3 was 98.0% in 2024. ▲ Rising
Immunization, Hib3 in Andorra, 1998–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
In 2024, immunization, hib3 in Andorra stood at 98.0%.
Compared with earlier readings it is up 1.0% on the previous year and up 1.0% over ten years.
Over the whole period, immunization, hib3 in Andorra peaked at 99.0% in 2011 and was at its lowest, 55.0%, in 1998.
That places Andorra 20th out of 191 countries with data for 2024, putting it in the top 10%.
The long-run direction has been consistently rising across the 27 years of available data.
Immunization, Hib3 in Andorra, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1998 | 55.0% | — |
| 1999 | 80.0% | +45.5% |
| 2000 | 90.0% | +12.5% |
| 2001 | 92.0% | +2.2% |
| 2002 | 92.0% | +0.0% |
| 2003 | 91.0% | -1.1% |
| 2004 | 95.0% | +4.4% |
| 2005 | 97.0% | +2.1% |
| 2006 | 93.0% | -4.1% |
| 2007 | 95.0% | +2.2% |
| 2008 | 98.0% | +3.2% |
| 2009 | 97.0% | -1.0% |
| 2010 | 98.0% | +1.0% |
| 2011 | 99.0% | +1.0% |
| 2012 | 98.0% | -1.0% |
| 2013 | 96.0% | -2.0% |
| 2014 | 97.0% | +1.0% |
| 2015 | 97.0% | +0.0% |
| 2016 | 98.0% | +1.0% |
| 2017 | 99.0% | +1.0% |
| 2018 | 99.0% | +0.0% |
| 2019 | 98.0% | -1.0% |
| 2020 | 98.0% | +0.0% |
| 2021 | 98.0% | +0.0% |
| 2022 | 97.0% | -1.0% |
| 2023 | 97.0% | +0.0% |
| 2024 | 98.0% | +1.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 67.5% | 55.0% | 80.0% | 2 |
| 2000s | 94.0% | 90.0% | 98.0% | 10 |
| 2010s | 97.9% | 96.0% | 99.0% | 10 |
| 2020s | 97.6% | 97.0% | 98.0% | 5 |
Countries ranked near Andorra
More health data for Andorra
- Heat deaths vs projected death rates, annual growth rate 0.0878 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,824 deaths per 1,000 people (2090)
- Un projection of annual infant deaths, annual growth rate -100 % change on previous year (2077)
- Number of infants who die before age 1 0 deaths (2100)
- Age population, age 07, female, interpolated 296 (2025)
- Age dependency ratio 39.2% (2025)
- Age population, age 06, male, interpolated 293 (2025)
- Age population, age 06, female, interpolated 266 (2025)
- Population, male 51.1% (2025)
- Age dependency ratio, young 16.2% (2025)
Frequently asked questions
- What is immunization, hib3 in Andorra?
- Immunization, hib3 in Andorra was 98.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Andorra?
- The highest recorded value was 99.0% in 2011.
- What is the lowest immunization, hib3 recorded in Andorra?
- The lowest recorded value was 55.0% in 1998.
- How does Andorra rank for immunization, hib3?
- Andorra ranks 20th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Andorra?
- Over the last ten years it is up 1.0%. The long-run trend across the full record is rising.
- Where does this Andorra data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 27 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.